Navigation Links
Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin

Patients with Parkinson’s disease may be able to stop or even slightly improve the progression of the disease if they undergo a surgical procedure to implant // embryonic cells into their brains, say researchers. The cells work by producing dopamine, a neurochemical that helps control movement. People with Parkinson’s don’t produce enough dopamine, which leads to the movement problems common in people with the condition.

Researchers compared 20 patients who had cells implanted with 19 patients who underwent a sham surgery for comparison purposes. All were tested for movement problems before the surgery and then again four months and 12 months later. Researchers then compared the scores between the two groups.

Results showed increasingly different scores for the two groups over time, with the greatest differences attributed to steadily worsening scores in the patients who did not receive the cell implants. Patients age 60 and older had the worst outcomes. Researchers believe the cell implants may have helped stabilize the brains of the patients who received them, suggesting the treatment could keep Parkinson’s disease from worsening.

Specialists say that this is an important beginning and they suggest additional studies in the area may one day lead to “highly specific and effective new genomic-based therapies.?
'"/>




Page: 1

Related medicine news :

1. Embryonic Genetic Testing Is Boosting IVF Pregnancies
2. T-cells Developed from Human Embryonic Stem Cells
3. Treatment of Spinal Cord Injury with Embryonic Stem Cells
4. Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning
5. Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation
6. Embryonic Selection of Sex can Avoid Conceiving Blind Children
7. Lipid Plays Big Role in Embryonic Development
8. Blood Cells Capable of Regenerating Liver
9. White Cells Count Can Predict Heart Attack Death Risk
10. Gene Therapy Destroys Pancreatic Cancer Cells
11. Stem Cells Have Few Mutations
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: